TV-119

Nov
21

Improving the Application of SDM into the Selection of SLE Treatments

Alzheimer’s disease (AD), a heterogeneous, neurodegenerative condition with an insidious onset and slow progression, is the leading cause of disability and morbidity as well as the sixth-leading cause of death in the United States. Diagnosing AD is often complicated due to its varied clinical symptomatology and unknown etiology, and currently only symptomatic therapies are available. […]

Read More
By Simone Kahmeyer |
DETAIL